T37.4X6A Underdosing of anthelminthics, initial encounter

Name of the Condition

• Underdosing of anthelminthics, initial encounter

Summary

This condition refers to insufficient dosing of anthelminthic medications during an initial encounter, which are used to treat parasitic worm infections. It may result in reduced treatment efficacy or failure to resolve the infection due to subtherapeutic drug levels. The initial encounter specifies this is the first time the underdosing is documented or addressed.

Causes

Underdosing can occur due to subtherapeutic dosing, patient non-adherence to prescribed regimens, formulation errors, or incorrect administration. It may also result from inadequate dosing based on weight, age, or infection severity, leading to insufficient drug exposure.

Risk Factors

• Patient non-adherence to medication schedules or dosing instructions.
• Incorrect dosing calculations or formulation errors.
• Lack of proper patient education on medication administration.
• Underlying conditions affecting drug absorption or metabolism.

Symptoms

• Persistent or worsening parasitic infection symptoms (e.g., abdominal pain, diarrhea, or visible worms).
• Treatment failure despite prescribed therapy.
• No improvement in infection-related signs or lab results.

Diagnosis

Clinical evaluation includes medication history, adherence assessment, and lab tests (e.g., parasitological exams or drug level checks). Diagnosis confirms underdosing as the cause of treatment failure, distinguishing it from other factors like resistance or incorrect diagnosis.

Treatment Options

Adjusting the anthelminthic dose to therapeutic levels, reinforcing patient education on adherence, or switching to an alternative agent if resistance is suspected. Close monitoring of infection resolution and symptom improvement is essential.

Prognosis and Follow-Up

Prognosis depends on timely dose correction and patient adherence. Follow-up involves re-evaluating infection status and ensuring therapeutic dosing is maintained to prevent recurrence or complications.

Complications

Prolonged infection, treatment failure, or progression of parasitic disease due to insufficient drug exposure. Severe cases may lead to organ damage or systemic illness if the infection is not controlled.

Lifestyle & Prevention

Ensuring proper medication storage, clear dosing instructions, and patient education on adherence. Regular follow-ups to monitor treatment response and address any barriers to compliance.

When to Seek Professional Help

If symptoms persist or worsen despite treatment, or if there are signs of treatment failure (e.g., unresolved infection, new complications). Seek care if dosing errors or adherence issues are suspected.

Tips for Medical Coders

Document the initial encounter context and evidence of underdosing (e.g., lab results, patient history). Ensure the code T37.4X6A is used only for the initial encounter of underdosing, with clear clinical justification for the diagnosis.